Patrick Gleason, PharmD, Shares Prime Therapeutics' Approach to Specialty Drug Management

Patrick Gleason, PharmD, FCCP, BCPS, director of health outcomes, Prime Therapeutics, says his organization's primary goal is to get patients the medications they need, and to control costs by keeping premiums down.
Published Online: April 02, 2014
Patrick Gleason, PharmD, FCCP, BCPS, director of health outcomes, Prime Therapeutics, says his organization’s primary goal is to get patients the medications they need, and to control costs by keeping premiums down.

He suggests that there are several aspects to specialty drug management, including the optimization of clinical care, cost sharing, pharmaceutical manufacturing, and patient assistance programs. By implementing 4 specific strategies, Prime Therapeutics saved their members $21 million through copay offsets. An estimated 19,000 members also benefited from copay coupons.



Compendia
Diabetes Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium